# TRANEXAMIC ACID IN SODIUM CHLORIDE

NDC: 51754-0108
Generic name: tranexamic acid
Labeler / Manufacturer: Exela Pharma Sciences, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20190601

FDA application: NDA212020

## Active ingredients

- TRANEXAMIC ACID: 10 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51754-0108"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51754-0108
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=db36ddf2-4ac5-47ac-bdce-e3fa6983073e